# What the study looked at Researchers examined brains donated by former NFL players who died between 2016 and 2021. Of 878 former players who died during that period, 235 donated their brains for postmortem neuropathological examination. Of those 235 brains, 215 were diagnosed with chronic traumatic encephalopathy (CTE).
# The headline numbers
- Conservative population estimate: when researchers incorporated the full set of 878 players who died during the period, they reported a conservative minimum prevalence of about 25% (roughly one in four).
# What CTE is and why diagnosis requires autopsy CTE is a progressive brain disease associated with repeated head impacts. It can be associated with mood and behavioral symptoms early on — for example, depression, anxiety, and aggression — and with memory loss and dementia later in life. Definitive diagnosis requires examination of brain tissue after death, so studies that rely on donated brains face inevitable selection effects.
# How researchers interpret the gap between samples
# Severity among diagnosed players According to the research team's follow-up, nearly two-thirds of players in the diagnosed group had dementia while alive. That indicates many cases in the donated sample were clinically severe, and those clinical impacts are a primary reason families sought neuropathological evaluation.
# What this means for younger and non-NFL players
# Immediate takeaways for readers If a family member or former player experienced progressive cognitive or behavioral changes after a career involving repeated head impacts, neuropathological evaluation can confirm CTE only after death. The study's conservative estimate — one in four former NFL players — signals the issue is not rare in the population that has played at the professional level, while also acknowledging uncertainty about the exact overall prevalence because of donor bias.
# Next steps the study points toward The authors call for broader, less biased population-level research to narrow the gap between conservative minimums and donated-sample prevalence. They also highlight the need to better understand which players develop symptomatic CTE and why, and to improve clinical approaches for living people who experienced repeated head impacts.